Results 221 to 230 of about 234,679 (371)

Air embolization of a left ventricular assist device in a child: an unusual case of a tension pneumothorax resulting in a fatal complication [PDF]

, 2019
Radosław Jaworski, Andrzej Kansy, Bohdan Maruszewski   +2 more
openalex   +1 more source

Left Ventricular Assist Devices and the Kidney.

American Society of Nephrology. Clinical Journal, 2017
Daniel W. Ross, G. Stevens, R. Wanchoo, David T. Majure, S. Jauhar, H. Fernandez, Massini A Merzkani, K. Jhaveri   +7 more
semanticscholar   +1 more source

Predictors of Aortic Valve Commissural Fusion in Patients Undergoing Left Ventricular Assist Device Therapy [PDF]

, 2015
Damian Valencia, S.A. Kliethermas, Joseph I. Bailey, B. Duebner, Edith Boyes, Jeffrey Schwartz, Alain Heroux, Erin Coglianese   +7 more
openalex   +1 more source

A fully magnetically levitated left ventricular assist device — final report [PDF]

, 2019
Ewald, G.A., Itoh, A.
core   +1 more source

Diagnosis of LVAD thrombus using a high-avidity fibrin-specific 99mTc probe [PDF]

, 2018
Akinobu Itoh, Anne H. Schmieder, Dmitry D. Beyder, Grace Cui, Gregory A. Ewald, Gregory M. Lanza, John S. Allen, Krishna S. Paranandi, Michael J. Scott, Michael Nassif, Samuel Achilefu, Walter J. Akers   +11 more
core   +2 more sources

Outcomes of Ventricular Tachycardia Ablation Using Percutaneous Left Ventricular Assist Devices

Circulation: Arrhythmia and Electrophysiology, 2017
S. Kusa, M. Miller, W. Whang, Yoshinari Enomoto, Jorge G. Panizo, J. Iwasawa, Subbarao Choudry, S. Pinney, Anthony Gomes, N. Langan, Jacob S. Koruth, A. d'Avila, V. Reddy, S. Dukkipati   +13 more
semanticscholar   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Use of 2 Ventricular Assist Devices as a Total Artificial Heart for Heart Failure. [PDF]

JACC Case Rep
Bradshaw A, Bradshaw JC, Briscoe JB, Shirodkar S, Pasrija C, Polanco A.   +5 more
europepmc   +1 more source

Complications, Risk Factors, and Staffing Patterns for Noncardiac Surgery in Patients with Left Ventricular Assist Devices

Anesthesiology, 2017
M. Mathis, S. Sathishkumar, S. Kheterpal, M. Caldwell, F. Pagani, E. Jewell, M. Engoren   +6 more
semanticscholar   +1 more source

eGFR slope as predictor of mortality in heart failure patients

ESC Heart Failure, Volume 12, Issue 2, Page 1217-1226, April 2025.
Abstract Aims Heart failure (HF) leads to an imbalance between heart and kidney function, resulting in poor outcomes. However, the prognostic significance of the estimated glomerular filtration rate (eGFR) trajectory in HF patients remains unclear. We analysed electronic health records (EHRs) of real‐world HF patients, assessing eGFR trajectories and ...
Sofie Verstreken, Monika Beles, Clara L. Oeste, Ana Moya, Imke Masuy, Riet Dierckx, Ward Heggermont, Jeroen Dauw, Dries Hens, Jozef Bartunek, Marc Vanderheyden   +10 more
wiley   +1 more source